医学
放射性骨坏死
头颈部癌
观察研究
科克伦图书馆
相对风险
梅德林
危险系数
放射治疗
荟萃分析
癌症
牙科
内科学
置信区间
政治学
法学
作者
Olivia Urquhart,Hillary R. DeLong,Kathleen M Ziegler,Lauren Pilcher,Sarah Pahlke,Malavika P. Tampi,Kelly K. O’Brien,Lauren L. Patton,Nishant Agrawal,Theresa M. Hofstede,Deepak Kademani,Mark W. Lingen,Nathaniel S. Treister,C. Jillian Tsai,Alonso Carrasco-Labra,Ruth D. Lipman
标识
DOI:10.1016/j.adaj.2022.06.003
摘要
The purpose of this systematic review was to examine whether dental intervention involving bone or soft-tissue manipulation preradiotherapy (pre-RT) is associated with lower rates of osteoradionecrosis of the jaw (ORNJ) in patients with head and neck cancer (HNC).The authors included relevant studies from MEDLINE, Embase, and Cochrane Library, including observational studies published from 2007 through 2021 and involving adults who underwent dental intervention pre-RT for HNC. Authors assessed evidence certainty by using the Grading of Recommendations Assessment, Development, and Evaluation approach. Random-effects models were used to calculate pooled relative risk estimates and hazard ratios. When meta-analysis was not possible, study-level measures of association and narrative summaries of the evidence were reported.Twenty-two studies were included. From the pooled, unadjusted analysis, patients undergoing pre-RT extractions may have a 55% increased risk of experiencing ORNJ (relative risk, 1.55; 95% CI, 0.85 to 2.86; very low certainty); the unadjusted pooled hazard ratio was 3.19 (95% CI, 0.99 to 10.31; very low certainty), corresponding to a possible increased hazard of developing ORNJ (very low certainty). Findings for other pre-RT procedures manipulating bone or tissue relied on limited, observational studies with low or very low certainty evidence.Mostly very low certainty evidence suggests that patients with HNC who need pre-RT dental intervention may have an increased risk of developing ORNJ compared with those who do not.Maintaining optimal oral health may help reduce the need for urgent pre-RT dental treatment, potentially reducing ORNJ risk and minimizing delay of oncologic treatment in patients with HNC.
科研通智能强力驱动
Strongly Powered by AbleSci AI